U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C17H23NO3.H2O4S
Molecular Weight 676.817
Optical Activity ( - )
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYOSCYAMINE SULFATE ANHYDROUS

SMILES

OS(O)(=O)=O.CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C3=CC=CC=C3.CN4[C@H]5CC[C@@H]4C[C@@H](C5)OC(=O)[C@H](CO)C6=CC=CC=C6

InChI

InChIKey=HOBWAPHTEJGALG-XHJLRQJWSA-N
InChI=1S/2C17H23NO3.H2O4S/c2*1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2*2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4)/t2*13-,14+,15+,16-;/m11./s1

HIDE SMILES / InChI

Molecular Formula C17H23NO3
Molecular Weight 289.3694
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C17H23NO3
Molecular Weight 289.3694
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry
Defined Stereocenters 3 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Hyoscyamine as a natural plant alkaloid derivative and anticholinergic. Hyoscyamine is used to treat a variety of stomach/intestinal problems such as cramps and irritable bowel syndrome. It is also used to treat other conditions such as bladder and bowel control problems, cramping pain caused by kidney stones and gallstones, and Parkinson's disease. In addition, it is used to decrease side effects of certain medications (drugs used to treat myasthenia gravis) and insecticides. Hyoscyamine inhibits specifically the actions of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of the smooth muscle, cardiac muscle, the sinoatrial node, the atrioventricular node, and the exocrine glands. At therapeutic doses, it is completely devoid of any action on autonomic ganglia. Side effects include dry mouth and throat, increased appetite leading to weight gain, eye pain, blurred vision, restlessness, dizziness, arrhythmia, flushing, and faintness. Additive adverse effects resulting from cholinergic blockade may occur when hyoscyamine is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
7.5 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Hospice use and outcomes in nursing home residents with advanced dementia.
2010-12
Biochemical and structural characterization of recombinant hyoscyamine 6β-hydroxylase from Datura metel L.
2010-12
Optimization of the culture medium composition to improve the production of hyoscyamine in elicited Datura stramonium L. hairy roots using the Response Surface Methodology (RSM).
2010-11-18
High-performance liquid-chromatographic tandem-mass spectrometric methods for atropinesterase-mediated enantioselective and chiral determination of R- and S-hyoscyamine in plasma.
2010-11-08
The pituri story: a review of the historical literature surrounding traditional Australian Aboriginal use of nicotine in Central Australia.
2010-09-12
An anesthetic experience with cesarean section in a patient with vasovagal syncope -A case report-.
2010-08
Differential production of tropane alkaloids in hairy roots and in vitro cultured two accessions of Atropa belladonna L. under nitrate treatments.
2010-07-27
An unusual case of anisocoria by vegetal intoxication: a case report.
2010-07-20
DFT-GIAO(1)H NMR chemical shifts prediction for the spectral assignment and conformational analysis of the anticholinergic drugs (-)-scopolamine and (-)-hyoscyamine.
2010-06
Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.
2010-04-07
"Divine stramonium": the rise and fall of smoking for asthma.
2010-04
Anisodamine production from natural sources: seedlings and hairy root cultures of Argentinean and Colombian Brugmansia candida plants.
2010-03
Production of tropane alkaloids during de-differentiation of Scopolia parviflora calli.
2010-02-26
Cementless total hip replacement: a prospective clinical study of the early functional and radiological outcomes of three different hip stems.
2010-01
Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.
2009-12
Tropane alkaloid profiling of hydroponic Datura innoxia Mill. Plants inoculated with Agrobacterium rhizogenes.
2009-11-12
Molecular cloning and characterization of two tropinone reductases in Anisodus acutangulus and enhancement of tropane alkaloid production in AaTRI-transformed hairy roots.
2009-10-23
Yeast cell factory: fishing for the best one or engineering it?
2009-10-12
The symptomatic management of multiple sclerosis.
2009-10
Mechanistic insights into the cytochrome P450-mediated oxidation and rearrangement of littorine in tropane alkaloid biosynthesis.
2009-09-21
Enantiomeric differentiation of atropine/hyoscyamine by (13) C NMR spectroscopy and its application to Datura stramonium extract.
2009-09-18
Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
2009-08-15
Assessment of the initial stability of the Symax femoral stem with EBRA-FCA: a multicentric study of 85 cases.
2009-05-21
Hyoscyamine biosynthesis in Datura stramonium hairy root in vitro systems with different ploidy levels.
2009-05
Molecular cloning and mRNA expression profiling of the first specific jasmonate biosynthetic pathway gene allene oxide synthase from Hyoscyamus niger.
2009-04
Cloning, characterization and analysis of expression profiles of a cDNA encoding a hyoscyamine 6beta-hydroxylase (H6H) from Atropa baetica Willk.
2009-01
Responses of fungi to tropane alkaloids produced by a medicinal plant Hyoscyamus muticus (Egyptian henbane).
2009
The scientific impact of microbial cell factories.
2008-12-01
A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women.
2008-09-27
The carbon-skeleton rearrangement in tropane alkaloid biosynthesis.
2008-08-13
[Determination of hyoscyamine and scopolamine in serum and urine of humans by liquid chromatography with tandem mass spectrometry].
2008-08
Sublingual hyoscyamine spray as premedication for colonoscopy: a randomized double-blinded placebo-controlled trial.
2008-07
Effect of chromium species on phytochemical and physiological parameters in Datura innoxia.
2008-06
Expression of Brugmansia candida Hyoscyamine 6beta-Hydroxylase gene in Saccharomyces cerevisiae and its potential use as biocatalyst.
2008-05-27
Characterization of Atropa belladonna L. compounds by capillary electrophoresis-electrospray ionization-time of flight-mass spectrometry and capillary electrophoresis-electrospray ionization-ion trap-mass spectrometry.
2008-05
Neurogenic bladder: etiology and assessment.
2008-04
Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy.
2008-02-02
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
2008-02
Synthesis and characterization of molecularly imprinted polymers for phenoxyacetic acids.
2008-01
Endoscopic findings in loin pain hematuria syndrome: concentric clot in calyceal fornices.
2008
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin.
2008
HPLC-atmospheric pressure chemical ionization mass spectrometric method for enantioselective determination of R,S-propranolol and R,S-hyoscyamine in human plasma.
2007-11-15
Nocturnal enuresis.
2007-10-01
Evaluation of the cholinergic and adrenergic effects of two tropane alkaloids from Erythroxylum pervillei.
2007-10
Molecular cloning and characterization of a new cDNA encoding hyoscyamine 6beta-hydroxylase from roots of Anisodus acutangulus.
2007-09-30
Tropane and nicotine alkaloid biosynthesis-novel approaches towards biotechnological production of plant-derived pharmaceuticals.
2007-08
Tropane alkaloids production in transgenic Hyoscyamus niger hairy root cultures over-expressing putrescine N-methyltransferase is methyl jasmonate-dependent.
2007-03
How polyamine synthesis inhibitors and cinnamic acid affect tropane alkaloid production.
2007-01
The development of anticholinergics in the management of COPD.
2007
The history of barbiturates a century after their clinical introduction.
2005-12
Patents

Sample Use Guides

1 to 2 tablets (0.125 mg) every four hours or as needed. Do not exceed 12 tablets in 24 hours.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:56:35 GMT 2025
Edited
by admin
on Mon Mar 31 20:56:35 GMT 2025
Record UNII
OB570Z127K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANHYDROUS HYOSCYAMINE SULFATE
MART.  
Preferred Name English
HYOSCYAMINE SULFATE ANHYDROUS
Common Name English
ANHYDROUS HYOSCYAMINE SULFATE [MART.]
Common Name English
1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-OL (-)-TROPATE (ESTER) SULFATE (2:1) (SALT)
Common Name English
BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, (3(S)-ENDO)-, SULFATE (2:1)
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
210-644-6
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
RXCUI
1742407
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
FDA UNII
OB570Z127K
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
DAILYMED
OB570Z127K
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
EPA CompTox
DTXSID001341118
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
CAS
620-61-1
Created by admin on Mon Mar 31 20:56:35 GMT 2025 , Edited by admin on Mon Mar 31 20:56:35 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY